Articles from BIOTECH Patent News (April 1, 2004)

1-32 out of 32 article(s)

Title	Type	Words
Abbott and Orion expand collaboration for injectable levosimendan.		860
Affymetrix announces expanded genomic technologies licensing program.		425
Alliance and IL YANG announce a licensing, development and marketing agreement for Oxygent in Korea.		675
Alliance and Nycomed announce collaboration agreement for Oxygent development in Europe.		545
Applera obtains United States patent.	Brief Article	61
AstraZeneca files suit against Eon for patent infringement.	Brief Article	170
Aventis obtains United States patent.	Brief Article	216
Bayer CropScience obtains United States patent.	Brief Article	56
BioDelivery announces licensing of its topical BioNasal amphotericin B for chronic sinusitis.		576
BioMarin to obtain pediatric business from Medicis.		1824
Centro Nacional de Investigaciones Cientificas obtains United States patent.	Brief Article	58
Duke obtains United States patent.	Brief Article	104
fqubed concludes technology licensing agreement with Pharmacopeia.		619
Genencor obtains United States patent.	Brief Article	106
Genentech/Chiron patent litigation decision affirmed by CAFC.	Brief Article	171
Genta and Aventis announce Genasense expanded access program for patients with advanced melanoma.		646
ID Biomedical signs agreement to acquire Shire vaccine business.		760
LAM Pharmaceutical expands intellectual property assets.		307
Lonza files patent infringement lawsuit against Nutraceutical International.	Brief Article	243
Maine Medical Center Research Institute obtains United States patent.	Brief Article	139
Medifast diabetic product receives patent.		359
Merska obtains United States patent.	Brief Article	268
MorphoSys widens scope of United States patent for HuCAL technology.		403
Novozymes obtains United States patent.	Brief Article	85
Rigel obtains United States patent.		36
Rockefeller University obtains United States patent.	Brief Article	165
Scotland awards grant to Viragen for cancer research.		510
St. Jude Children's Research Hospital obtains United States patent.	Brief Article	106
Suntory obtains United States patent.	Brief Article	81
Syngenta granted fifth transgenic Bt patent - files suit against competitors.	Brief Article	221
Warner-Lambert obtains United States patent.	Brief Article	69
Xanthus receives patent on lead anti-cancer compound Xanafide amonafide.		362